K. Danielsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
K. Danielsen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
A.O. Olsen
Department of Rheumatology Dermatology and Infectious Diseases The Olafia Clinic Oslo University Hospital Oslo Norway
2 shared publicationsT. Wilsgaard
Department of Community Medicine Faculty of Health Sciences UiT The Arctic University of Norway Tromsø Norway
2 shared publicationsA.-S. Furberg
Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway
1 shared publicationA.E. Eggen
Department of Community Medicine Faculty of Health Sciences UiT The Arctic University of Norway Tromsø Norway
1 shared publicationA.‐S. Furberg
Department of Community Medicine Faculty of Health Sciences UiT The Arctic University of Norway Tromsø Norway
1 shared publicationK. Olsen
Department of Community Medicine Faculty of Health Sciences UiT The Arctic University of Norway Tromsø Norway
1 shared publication
Latest Publications
- Open Access
- 25 December 2014
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 172 (2) , 419-427
Elevated odds of metabolic syndrome in psoriasis: a population‐based study of age and sex differences
Questions remain concerning to what extent age and sex may modify the suggested association between psoriasis and the metabolic syndrome in the general population. To investigate the association between psoriasis and the metabolic syndrome within a large population-based cohort by age and sex. A cross-sectional study including 10 521 participants aged 30-79 years from the Tromsø Study cohort was performed; 1137 participants reported lifetime psoriasis of a mainly mild character. The new harmonized definition of metabolic syndrome was used in the multivariable logistic regression analysis. There was a uniformly higher prevalence of metabolic syndrome in men and women with psoriasis compared with those without across all age groups. In women, psoriasis was associated with a 3·8-times higher odds of metabolic syndrome at age 30 years (95% confidence interval 1·5-9·7), with a decreasing odds ratio with increasing age. In men, psoriasis was associated with a stable 1·35-times higher odds of metabolic syndrome (95% confidence interval 1·1-1·6) at all ages. Abdominal obesity was the most frequent metabolic syndrome component in women in this study, and there was indication of a dose-response relationship between psoriasis severity, indicated through treatment, and having a high waistline in women. This study suggests age and sex variations in the risk of metabolic syndrome among individuals with psoriasis. Given the high prevalence of psoriasis and the significantly elevated burden of metabolic syndrome in this patient group, there may be a benefit from targeted screening of metabolic syndrome among individuals with psoriasis regardless of age and disease severity.
- 25 December 2014
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 172 (2) , 419-427
Open AccessElevated odds of metabolic syndrome in psoriasis: a population‐based study of age and sex differences
Questions remain concerning to what extent age and sex may modify the suggested association between psoriasis and the metabolic syndrome in the general population. To investigate the association between psoriasis and the metabolic syndrome within a large population-based cohort by age and sex. A cross-sectional study including 10 521 participants aged 30-79 years from the Tromsø Study cohort was performed; 1137 participants reported lifetime psoriasis of a mainly mild character. The new harmonized definition of metabolic syndrome was used in the multivariable logistic regression analysis. There was a uniformly higher prevalence of metabolic syndrome in men and women with psoriasis compared with those without across all age groups. In women, psoriasis was associated with a 3·8-times higher odds of metabolic syndrome at age 30 years (95% confidence interval 1·5-9·7), with a decreasing odds ratio with increasing age. In men, psoriasis was associated with a stable 1·35-times higher odds of metabolic syndrome (95% confidence interval 1·1-1·6) at all ages. Abdominal obesity was the most frequent metabolic syndrome component in women in this study, and there was indication of a dose-response relationship between psoriasis severity, indicated through treatment, and having a high waistline in women. This study suggests age and sex variations in the risk of metabolic syndrome among individuals with psoriasis. Given the high prevalence of psoriasis and the significantly elevated burden of metabolic syndrome in this patient group, there may be a benefit from targeted screening of metabolic syndrome among individuals with psoriasis regardless of age and disease severity.
- Top Cited Papers
- 1 February 2013
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 168 (6) , 1303-1310
Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort
Background There is indication of an increasing prevalence of psoriasis in some western populations. However, the results are not conclusive. Objectives To analyse trends in the prevalence of psoriasis over the past 30 years, separating age, birth cohort and time period effects. Methods Five population-based surveys in North Norway, the Tromsø Studies 2–6, collected between 1979 and 2008, were studied. Participants aged 20–79 years with self-reported psoriasis data in at least one of the surveys were included, yielding a total of 69 539 observations from 33 387 unique individuals born between 1915 and 1977. Trends in psoriasis prevalence were examined using cross-sectional, time lag and longitudinal designs of graphical plots. Observed trends were further evaluated in generalized linear-regression models. Results The self-reported lifetime prevalence of psoriasis increased from 4·8% in 1979–1980 to 11·4% in 2007–2008. Graphical plots showed an increasing prevalence of psoriasis with each consecutive survey in all examined age groups and birth cohorts, leaving time period effects as the explanation for the increase. The odds for psoriasis in the cohort were 2·5 times higher in 2007–2008 than in 1979–1980 (adjusted odds ratio 2·49, 95% confidence interval 2·08–2·99). The prevalence of persons reporting a doctor’s diagnosis of psoriasis was 9·9% in the last survey. In subgroups of the study population, psoriasis was associated with higher body mass index, lower physical activity during work and leisure time, lower educational level and smoking. Conclusions Our findings indicate an increasing prevalence of self-reported psoriasis. This could represent a true increase in prevalence, possibly due to changes in lifestyle and environmental factors, or an increased awareness of the disease.
- 1 February 2013
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 168 (6) , 1303-1310
Top Cited PapersIs the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort
Background There is indication of an increasing prevalence of psoriasis in some western populations. However, the results are not conclusive. Objectives To analyse trends in the prevalence of psoriasis over the past 30 years, separating age, birth cohort and time period effects. Methods Five population-based surveys in North Norway, the Tromsø Studies 2–6, collected between 1979 and 2008, were studied. Participants aged 20–79 years with self-reported psoriasis data in at least one of the surveys were included, yielding a total of 69 539 observations from 33 387 unique individuals born between 1915 and 1977. Trends in psoriasis prevalence were examined using cross-sectional, time lag and longitudinal designs of graphical plots. Observed trends were further evaluated in generalized linear-regression models. Results The self-reported lifetime prevalence of psoriasis increased from 4·8% in 1979–1980 to 11·4% in 2007–2008. Graphical plots showed an increasing prevalence of psoriasis with each consecutive survey in all examined age groups and birth cohorts, leaving time period effects as the explanation for the increase. The odds for psoriasis in the cohort were 2·5 times higher in 2007–2008 than in 1979–1980 (adjusted odds ratio 2·49, 95% confidence interval 2·08–2·99). The prevalence of persons reporting a doctor’s diagnosis of psoriasis was 9·9% in the last survey. In subgroups of the study population, psoriasis was associated with higher body mass index, lower physical activity during work and leisure time, lower educational level and smoking. Conclusions Our findings indicate an increasing prevalence of self-reported psoriasis. This could represent a true increase in prevalence, possibly due to changes in lifestyle and environmental factors, or an increased awareness of the disease.